Results 111 to 120 of about 6,428 (208)

Rimonabant (acomplia®), obésité et diabiète de type 2

open access: yes, 2008
Le rimonabant (Acomplia®) est une molécule au mécanisme d'action original, antagoniste du récepteur CB1 du système endocannabinoïde qui joue un rôle majeur dans la régulation de l'équilibre énergétique du corps.
BESSIERES, Hélène   +1 more
core  

Modulating the endocannabinoid system in alcohol use disorder: A translational systematic review and meta-analysis of preclinical and human studies. [PDF]

open access: yesMol Psychiatry
Costa GPA   +7 more
europepmc   +1 more source

Rimonabant n,n-dimethylformamide solvate, and method for preparing same

open access: yes, 2007
The invention relates to a rimonabant N,N-dimethylformamide solvate, and to a method for preparing the ...
Coquerel, Gérard, Fours, Baptiste
core  

Glucocorticoid-endocannabinoid crosstalk in the ventrolateral periaqueductal gray (vlPAG) promotes pain resolution. [PDF]

open access: yesNeuropsychopharmacology
Coutens B   +9 more
europepmc   +1 more source

Minor cannabinoids CBD, CBG, CBN, and CBC differentially modulate sensory neuron activation. [PDF]

open access: yesJ Pharmacol Exp Ther
Rabl K   +5 more
europepmc   +1 more source

Targeting dysregulated CB1 receptors in a Down syndrome mouse model improves neurological outcomes. [PDF]

open access: yesAlzheimers Dement
Vázquez-Oliver A   +8 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy